Skip to main content
. Author manuscript; available in PMC: 2013 Jul 1.
Published in final edited form as: Jt Comm J Qual Patient Saf. 2012 May;38(5):195–206. doi: 10.1016/s1553-7250(12)38025-2

Table 2.

Summary of Inpatient Glucometrics for Intensive Care Unit (ICU) and Non-ICU Settings*

Glucometric Model Numerator Denominator Interpretation Advantages Disadvantages
Population All glucose measurements over a given time period None Mean or median of all BGs
% of all readings within a given glucose category
  1. Largest sample size

  2. Easiest to generate

  3. Useful for evaluating IV insulin protocols

  1. Doesn’t account for clustering of repeated measures

  2. Skews data toward patients with long hospital stays

  3. Limited utility outside of the ICU

Patient-day All glucose measurements over a given time period Average number of blood glucose readings collected per patient-hospital day Mean or median patient-day–weighted blood glucose
% of patient-days with mean BG within a given glucose category
% of patient-days with any episode of adverse glucose outcomes.
  1. Most clinically relevant

  2. Appropriately accounts for differences in glucose testing frequency

Skewed somewhat toward patients with long hospital stays
Patient-stay All glucose measurements over a given time period Average number of blood glucose readings collected per patient-hospital stay Mean patient-day– weighted BG for a patient’s hospital stay
% of patient stays with day-weighted mean BG falling within a given glucose category.
Best single measure of long-term glycemic control in a given patient
  1. Least powered to detect meaningful changes

  2. Doesn’t account for differences in lengths of stay

  3. Cannot be used to accurately gauge the frequency of adverse glycemic events

*

BG, blood glucose; IV, intravenous.